U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536620) titled 'Metformin and Alveolar Cleft' on April 11.
Brief Summary: * Completed medical history will take for all patients. All patients' guardians were informed about the procedure, the possible postoperative complications, and requested to sign an informed consent that was translated into Arabic language.
* Patients were randomly divided into two equal groups by means of sealed envelopes:
* Group A ( study group) 18 patients who received a combination of illiac cancellous bone graft and 2ml of 1% metformin gel (20mg of metformin with 2% hydroxymethyl cellulose)
* Group B (control group): 18 patients who received illiac cancellous bone g...